Work

Publisher Correction: ILC1s control leukemia stem cell fate and limit development of AML

Year: 2022

Type: erratum

Source: Nature Immunology

DOI: 10.1038/s41590-022-01265-4

Authors: Zhenlong Li, Rui Ma, Shoubao Ma, Lei Tian, Ting Lu, Jianying Zhang, Bethany L. Mundy-Bosse, Bin Zhang, Guido Marcucci, Michael A. Caligiuri, Jianhua Yu

Institutions: City Of Hope National Medical Center, The Ohio State University Wexner Medical Center, The Ohio State University, City of Hope

Language: English

Topic: IL-33, ST2, and ILC Pathways

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4282926642

Cites:

Cited by: 3

Related to: 10